898746-82-2

Usage

Synthesis

Tert-butyl 6-fluoro-5-hydroxy-1H-indazole-1-carboxylate was prepared as described for intermediate tert-butyl 5-hydroxy-1H-indazole-1-carboxylate/ tert-butyl 5-hydroxy-2H-indazole-2- carboxylate replacing tert-butyl 5-((tert-butyldimethylsilyl)oxy)-1H-indazole-1-carboxylate / tert-butyl 5-((tertbutyldimethylsilyl) oxy)-2H-indazole-2-carboxylate with tert-butyl 5-((tert-butyldimethylsilyl)oxy)-6-fluoro-1H-indazole-1-carboxylate(yield: 94%). 1H NMR (400 MHz, Chloroform-d) δ 8.06 (d, J = 0.9 Hz, 1H), 7.95 (d, J = 10.7 Hz, 1H), 7.28 (d, J = 8.2 Hz, 2H), 5.48 (s, 1H), 1.71 (s, 9H).

Upstream product

• 15903-94-3 6-benzyloxy-1H-indole 
• 2380-86-1 6-hydroxy-1H-indole 
• 24424-99-5 di-tert-butyl dicarbonate 
• 933474-39-6 6-benzyloxy-indole-1-carboxylic acid tert-butyl ester 

Downstream Products

• 200207-21-2 6-(difluoromethoxy)-1H-indole 

Relevant academic research and scientific papers

Rapid access to spirocyclic oxindole alkaloids: Application of the asymmetric palladium-catalyzed [3 + 2] trimethylenemethane cycloaddition

The marcfortines are complex secondary metabolites that show potent anthelmintic activity and are characterized by the presence of a bicyclo[2.2.2]diazaoctane fused to a spirooxindole. Herein, we report the synthesis of two members of this family. The syn

PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES

The present invention relates to pyridinyl and pyrazinyl-(aza)indolsulfonamides having GPR17 modulator activity. The compounds have utility in the treatment of a variety of GPR17-associated disorders.

P300/CBP HAT INHIBITORS

Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with histone acetyltransferase (HAT).

Ligand compound of alpha7 nicotinic acetylcholine receptor and application of ligand compound

The embodiment of the invention provides a ligand compound of an alpha7 nicotinic acetylcholine receptor, the ligand compound has one of the following general formulas: wherein (1) X and R1 are shown in the description, and R7 is halogen; (2) R2 is hydrogen, and R3 is halogen or amino; or R3 is hydrogen, and R2 is halogen or amino; (3) R6 is hydrogen, and R4 and R5 are synthesized into a compound shown in the description; or R4 is hydrogen, and R5 and R6 are synthesized into a compound shown in the description; R8 is halogen; and (4) Y is nitrogen or carbon, Z is shown in the description, and R9 and R10 are respectively halogens. The provided ligand compound is an excellent ligand compound of the alpha7 nicotinic acetylcholine receptor. After being chemically marked radioactively, the provided ligand compound of the alpha7 nicotinic acetylcholine receptor can serve as a PET photographic developer.

Concise, asymmetric, stereocontrolled total synthesis of stephacidins A, B and notoamide B

Concise asymmetric total syntheses of the fungal metabolites (-)-stephacidin A, (+)-stephacidin B, and (+)-notoamide B are described. Key features of these total syntheses include (1) a facile synthesis of (R)-allyl proline methyl ester, (2) a revised rou

Concise syntheses of the 1,7-dihydropyrano[2,3-g]indole ring system of the stephacidins, aspergamides and norgeamides

Three approaches towards the synthesis of the 1,7-dihydropyrano[2,3-g] indole ring system of the stephacidins, paraherquamides and norgeamides have been investigated. The first involves a tandem nitrene insertion/aromatic Claisen rearrangement. The second